Development and validation of phosphonate-based inhibitors and activity-based probes (ABPs) for detection and pharmacological targeting of kallikreins
The generation of a novel activity-based probe (ABP) and inhibitor specific for kallikrein 7 (KLK7) and validation of its therapeutic effects in vivo is described here. KLK7 is a protease with well-established functions in skin inflammation and overdesquamation and in cancer. ABPs, on the other hand...
Main Author: | Μπισύρης, Ευάγγελος |
---|---|
Other Authors: | Bisyris, Evangelos |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10889/15718 |
Similar Items
-
Validation of activity-based probes (ABPs) and inhibitors specific for the KLK6 protease in vitro
by: Γιαννακοπούλου, Χριστίνα
Published: (2020) -
Generation and characterization of novel mouse models to validate the role of KLK5 protease in inflammation for pharmacological applications
by: Ζήνγκου, Ελένη
Published: (2019) -
Περιγεννητικοί παράγοντες που σχετίζονται με την εμφάνιση αλλεργικών νοσημάτων στην παιδική ηλικία
by: Παπαθωμά, Ευαγγελία
Published: (2017) -
Μελέτη του μηχανισμού φαρμακολογικής ρύθμισης του γονίδιου της καλλικρεϊνης 6 και ανάλυση της μεθυλίωσης DNA για ανάπτυξη διαγνωστικών
by: Παμπαλάκης, Γιώργος
Published: (2007) -
Tomography
Published: (2021)